E. Cvitkovic Et Al. , "Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (>=N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival," INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.35, no.3, pp.463-469, 1996
Cvitkovic, E. Et Al. 1996. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (>=N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.35, no.3 , 463-469.
Cvitkovic, E., ESCHWEGE, F., RAHAL, M., DOSEN, .., MERSİC, Z., KRAJİNA, Z., ... ARMAND, J.(1996). Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (>=N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.35, no.3, 463-469.
Cvitkovic, E Et Al. "Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (>=N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival," INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.35, no.3, 463-469, 1996
Cvitkovic, E Et Al. "Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (>=N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival." INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.35, no.3, pp.463-469, 1996
Cvitkovic, E. Et Al. (1996) . "Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (>=N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival." INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , vol.35, no.3, pp.463-469.
@article{article, author={E Cvitkovic Et Al. }, title={Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (>=N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival}, journal={INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS}, year=1996, pages={463-469} }